Related Experiment Videos
Sevelamer
1Oxford Kidney Unit, Churchill Hospital, Oxford, UK.
Nephron. Clinical Practice
|August 7, 2003
Abstract:
Hyperphosphataemia in patients with chronic renal failure has traditionally been treated with calcium- and aluminium-containing phosphate binders. This article briefly discusses the rationale and complications of these treatments and reviews sevelamer that is a novel non-calcium-, non-aluminium-containing phosphate binder and the evidence to support its use in clinical practice.